Catalyst Pharmaceutical Partners Inc buy Robert W. Baird
Start price
04.02.25
/
50%
€22.14
Target price
04.02.26
€27.08
Performance (%)
-9.12%
Price
12.12.25
€20.12
Summary
This prediction is currently active. With a performance of -9.12%, the BUY prediction by Robert_W__Baird is trending in the wrong direction. This prediction currently runs until 04.02.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -0.396% | -0.396% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Robert_W__Baird for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $28.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Robert_W__Baird for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€22.15
03.03.25
03.03.25
€30.55
03.03.26
03.03.26
-9.16%
12.12.25
12.12.25
